1e
19
1
49
2
2
18
1b
1d
18
31
48
1d
2 29
1d
25
George E. Woody, MD
88
48
Emeritus Professor CE of Psychiatry
7
61
Department: Psychiatry
4
1
b
1d
46
Contact information
66
4
3
3
3
2
4
b
1f
66
3535 Market Street, 5th floor
Philadelphia, PA 19104
26
Philadelphia, PA 19104
30
Office: (215) 746-7702
30
9b
12
30
13
Education:
21 9 B.A. 14 (History) c
29 Amherst College , 1960.
21 9 M.D. 17 (Psychiatry) c
2a Temple University, 1964.
c
3
3
3
3
8a
Permanent link21 9 B.A. 14 (History) c
29 Amherst College , 1960.
21 9 M.D. 17 (Psychiatry) c
2a Temple University, 1964.
c
2 29
21
1e
1d
24
5e
65
1a 29
27
Description of Research Expertise
55 Substance abuse treatment outcome; dual diagnosis; HIV risk reduction65
Description of Clinical Expertise
3d Substance abuse treatment; general psychiatry1a 29
23
120 Adams EH, Breiner S, Cicero TJ, Geller A, Inciardi JA, Schnoll SH, Senay EC, Woody GE: A comparison of the abuse liability of tramadol, NSAIDS and hydrocodone in patients with chronic pain. 2005 Notes: Under review.
ed Forman R, Woody G, McLellan T: Availability of websites offering to sell opioid-containing medications without a prescription. Am J Psychiatry 2005 Notes: In press.
192 Ling W, Amass L, Shoptaw S, Annon JJ, Babcock D, Brigham G, Harrer J, Reid M, Buchan B, Orr D, Woody G, Krejci J, et al: A multi-center randomized trial of buprenorphine-naloxone and clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Dependence 2005 Notes: In press.
ae Dart R, Woody GE, Kleber HD: Prescribing methadone as an analgesic. Ann Int Med 2005 Notes: In Press.
fe Thompson R, Kane V, Cook J, Waler P, Greenstein R, Woody G: Predictors of suicidal ideation in patients receiving methadone maintenance. J Psychoactive Drugs 2004-5 Notes: In press.
166 Krupitsky EM, Zvartau EE, Masalov DV, Tsoi MV, Burakov AM, Egorova VY, Didenko TY, Romanova TN, Ivanova EB, Bespalov AY, Verbitskaya EVV, Neznanov NG, Grinenko AY, O'Brien CP, Woody GE: Naltrexone for heroin dependence treatment in Russia. J Subst Abuse Treatment 26(4): 285-294, 2004.
7a Woody, G.E., Gallop, R., Luborsky, L., Blaine, J., Frank, A., Gastfriend, D., ca Crits-Christoph, P.: and the Cocaine Psychotherapy Study Group. HIV risk reduction in the NIDA cocaine psychotherapy study. J. Acq. Immune Def. Syndromes 33: 82-87, 2003.
12b Senay, E.C., Cicero, T.J., Geller, Woody, G.E. A., Adams, E.H., Inciardi, J.A., Munoz, A., Schnoll, S.H.: Typical and atypical withdrawal from Ultram (tramadol hydrochloride). Drug and Alcohol Dependence 2003 Notes: In press.
7a Woody, G.E., Gallop, R., Luborsky, L., Blaine, J., Frank, A., Gastfriend, D., cf Crits-Christoph, P.: and the Cocaine Psychotherapy Study Group. HIV risk reduction in the NIDA cocaine psychotherapy study. J. Acq. Immune Def. Syndromes 2003 Notes: In press.
2c
7
1d
1f
Selected Publications
159 Cicero TJ, Inciardi JA, Adams EH, Geller A, Senay EC, Woody GE: Rates of abuse of tramadol remain unchanged with the introduction of new branded generic products: results of an abuse monitoring system, 1994-2004. Pharmacoepidemiology and Drug Safety 2005 Notes: In press.120 Adams EH, Breiner S, Cicero TJ, Geller A, Inciardi JA, Schnoll SH, Senay EC, Woody GE: A comparison of the abuse liability of tramadol, NSAIDS and hydrocodone in patients with chronic pain. 2005 Notes: Under review.
ed Forman R, Woody G, McLellan T: Availability of websites offering to sell opioid-containing medications without a prescription. Am J Psychiatry 2005 Notes: In press.
192 Ling W, Amass L, Shoptaw S, Annon JJ, Babcock D, Brigham G, Harrer J, Reid M, Buchan B, Orr D, Woody G, Krejci J, et al: A multi-center randomized trial of buprenorphine-naloxone and clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Dependence 2005 Notes: In press.
ae Dart R, Woody GE, Kleber HD: Prescribing methadone as an analgesic. Ann Int Med 2005 Notes: In Press.
fe Thompson R, Kane V, Cook J, Waler P, Greenstein R, Woody G: Predictors of suicidal ideation in patients receiving methadone maintenance. J Psychoactive Drugs 2004-5 Notes: In press.
166 Krupitsky EM, Zvartau EE, Masalov DV, Tsoi MV, Burakov AM, Egorova VY, Didenko TY, Romanova TN, Ivanova EB, Bespalov AY, Verbitskaya EVV, Neznanov NG, Grinenko AY, O'Brien CP, Woody GE: Naltrexone for heroin dependence treatment in Russia. J Subst Abuse Treatment 26(4): 285-294, 2004.
7a Woody, G.E., Gallop, R., Luborsky, L., Blaine, J., Frank, A., Gastfriend, D., ca Crits-Christoph, P.: and the Cocaine Psychotherapy Study Group. HIV risk reduction in the NIDA cocaine psychotherapy study. J. Acq. Immune Def. Syndromes 33: 82-87, 2003.
12b Senay, E.C., Cicero, T.J., Geller, Woody, G.E. A., Adams, E.H., Inciardi, J.A., Munoz, A., Schnoll, S.H.: Typical and atypical withdrawal from Ultram (tramadol hydrochloride). Drug and Alcohol Dependence 2003 Notes: In press.
7a Woody, G.E., Gallop, R., Luborsky, L., Blaine, J., Frank, A., Gastfriend, D., cf Crits-Christoph, P.: and the Cocaine Psychotherapy Study Group. HIV risk reduction in the NIDA cocaine psychotherapy study. J. Acq. Immune Def. Syndromes 2003 Notes: In press.
2c